The Center for Technology Licensing (CTL) at Weill Cornell is pleased to present the next in the CTL@WCM Special Panel Series. A new generation of non-animal model systems are coming to the forefront of drug development, including organoid, chip-based, and in silico platforms. These cutting-edge technologies are gaining increasing scientific, commercial, and regulatory acceptance, accelerated…
